CVKDCadrenal Therapeutics, Inc. · Nasdaq Capital Market · $3.42M mkt cap
Assessed Sep 1, 2026 · Reassessment
Is the float you're seeing correct?
3.17M
Estimated float

Cover-page shares outstanding as of 2026-08-13 (3,567,592) less Quang Pham's direct 98,589 shares and 200,000 shares held indirectly through the PVBQ Living Trust.

Confirmed · within 2%
3.22M
Reported float

Data-service feed, fetched today. The number TradingView and most screeners show.

Your screener's float is right for CVKD. Trade off 3.17M shares. What it does not show you is what is about to be added to it.

Dilution risk7/10HIGH
CONFIDENCE: MEDIUM

The float your screener shows is right, at 3.17M. Registered and convertible shares could add another 154% of the float.

  • Warrant overhang concentrated in a single counterparty. Total warrants outstanding of 4,595,140 as of 2026-06-30 equal 145% of the 3.17M reported float and 129% of the 3,567,592 shares outstanding.

  • Rapid share count growth. Deterministic XBRL share history shows outstanding growing from 1,658,771 (2024-11-07) to 3,567,592 (2026-08-13) — a 115% increase in twelve months and a 24.4% increase in the single quarter from 202…

  • Near-zero-strike pre-funded warrants outside the float. 960,000 pre-funded warrants were issued at a $0.0001 exercise price in the July 2026 PIPE; 469,000 were exercised in July 2026, leaving 491,000 outstanding with NO EXPIRATION DATE — they do not expir…

From today's float to the ceiling

shares
3.17M
Estimated float
tradeable today
+1.45M can sell now
4.62M
Effective supply
float plus what sells on notice
+4.04M if floors are cut and warrants exercise
8.66M
Fully diluted
ceiling

Ceiling computed from the itemised overhang.

Where the shares come from

each subtotal is a rung on the ladder above

Tradeable today
3.17M
Can sell now
Registered resale shares, issuable on notice
Already effective; the holder can sell without a further filing.
+960.0K
Warrants in the money, at or near a zero strike
Exercisable at or below the current tape.
+491.0K
Effective supply
4.62M
Above the current price
Warrants out of the money
Struck above the current tape; supply only if the stock rises.
+3.64M
Options and RSUs
Employee equity; vests and settles over time.
+403.0K
Fully diluted
8.66M

Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.

Engine fully-diluted count (8.10M) is below the itemised overhang; ceiling computed from the rows.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue

The facts

Price
—
Market cap
$3.42M
Shares outstanding
3.57M
Reported float
3.22M
Avg volume
140.6K
Reverse splits
1 · latest 1-for-15 · Aug 20, 2024
Going concern
Yes · 1.7 quarters runway
Quarterly burn
$2.50M

Market data as of Oct 25, 2026

Key dates

  • Oct 29, 2026 · Series B-2 Warrants (571,430 shares at $4.50) reach the 18-month mark from the 2026-04-29 registration effectiveness — expiration deadline creates an inducemen…
  • Dec 31, 2026 · 2025 Common Warrants (414,748 at $10.60) and 2025 PA Warrants (13,479 at $13.5625) expire
  • Jan 1, 2027 · 2022 Plan evergreen reset — reserve recalculates to 20% of outstanding plus warrant shares, potentially ~1.63M shares
  • Jul 20, 2027 · PIPE one-year prohibition on variable-rate transactions expires, removing the contractual block on death-spiral-style structures
CVKD Float & Dilution Analysis | ShareStructure.io